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1. Introduction
  Recent researches show that tumor stem cells (TSCs) 
account for only a small part in the overall tumor cells, 
which cause relapse, metastasis and growth of neoplasms. 
In recent years, foreign and domestic scholars have 
successfully separated brain tumor stem cells (BTSCs)
[1] from glioma tissue and cell lines, which play a pivotal 
role in glioma initiation, growth and recurrence. A prior 
study[2] demonstrated that via Notch signaling pathway, 
the key protein is expressed abnormally during tumor 
cells proliferation, primarily mediating self-renewal, 
proliferation and differentiation of normal stem cells and 
TSCs. It is of great significance to inhibit Notch pathway and 
the proliferation of TSCs at the same time. 毭-secretase, the 
key enzyme during the Notch signaling activation, plays an 
important role in cascade reactions. 毭-secretase inhibitors 
may block Notch intracytoplasmic domain (NICD) generation 
in Notch signaling pathway, thus suppress abnormal cells 
differentiation and proliferation in NICD. However, there are 
fewer reports that 毭-secretase inhibitors disturbing TSCs 
survivals due to blocking or inhibiting Notch pathway which 
will eventually cure tumor.
  N-[N-(3,5-difluorophenyl acetyl)-L-alanyl]-S-
phenylglycine butyl ester (DAPT), an artificially synthesized 
毭-secretase inhibitor, is well-known for blocking Notch 
signaling pathway. However, there are few studies on DAPT 
in the field of anti-tumor effect. Further studies are still 
needed to cure tumor radically through suppressing TSCs 
proliferation due to Notch signaling pathway blockade. 
Therefore, 毭-secretase inhibitor DAPT will be used to treat 
human glioma cell line SHG-44. Notch pathway and TSCs 
quantities change will be determined and suppression effect 
of DAPT on cell line SHG-44 proliferation will be analyzed. 
We will explore the possible mechanism and provide new 
ideas and theoretical basis for glioma treatment.
2. Materials and methods
2.1. Cell lines 
  SHG-44 human glioma cell line was obtained from the Cell 
Objective: To explore the suppressing effect of 毭-secretase inhibitor DAPT on proliferation 
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Bank of the Chinese Academy of Sciences (Shanghai, China).
2.2. Reagents and Instruments 
  L-DMEM medium was purchased from Hyclone, USA. 
Fetal calf serum was obtained from Hangzhou Sijiqing 
Bioengineering Material Co., Ltd. Total RNA Kit was 
purchased from Nanjing KeyGEN Biotech Co., Ltd.  One-Step 
RT-PCR Kit were purchased from Tiangen Biotech(Beijing)
Co., Ltd.  DAPT was obtained from Alexis Corporation, 
Switzerland. Propidium iodide (PI) and MTT were purchased 
from Amersco Corporation, USA. Anti-Notchl, Anti-Deltal 
and Anti-Hesl were products of Chemicon Corporation, USA. 
Primers were synthesized by Sangon Biotech (Shanghai) Co., 
Ltd. The major devices used are as the following: gel imaging 




 Frozen cell line SHG-44 was resuscitated. Cells were 
incubated in L-DMEM containing 10% fetal bovine serum 
(FBS) at 37 曟 in a 5% CO2 saturated humidity incubator. 
Media was changed every 3 d. When cells reached a >90% 
confluent monolayer, cells were passaged into new tissue 
culture flasks.
2.3.2. Randomization
  SHG-44 cells were randomized into five groups in which 
different concentrations of DAPT were applied (Group A: 
0 毺mol/L; Group B: 0.5 毺mol/L; Group C: 1.0 毺mol/L; 
Group D: 5.0 毺mol/L; Group E: 10.0 毺mol/L). Incubation 
continued at 37曟 and 5% CO2 in saturated humidity. Culture 
medium was changed every 3 days. 
2.3.3. Suppression effect of DAPT on SHG-44 cells 
proliferation by MTT
  Subcultured SHG-44 cells were obtained after 0.25% 
trypsin digestion. Cells were seeded onto 96 well plates with 
a density of 1伊104 cells/mL and incubated for 24 h. Then 
DAPT was added according to the groups. One plate was 
taken out every 24 h during 5 d and 20 毺L MTT was added 
to each well (5 mg/mL). Plates were incubated at 37 曟 for 
4 h, then the medium was discarded. DMSO 150 毺L was 
added in each well and shaked for 10 min. Optical density 
(OD value) were determined at 570 nm by MTT enzyme-
linked immunometric meter. Cell proliferation curves of 
each group were obtained.
2.3.4. Cell cycle detection by flow cytometry (FCM)
  Different concentrations of DAPT treated SHG-44 cells were 
collected from the above 5 groups after about 48 h. They 
were digested with 0.25% trypsin, counted and adjusted to 1
伊106/mL. The cells were precipitated by centrifugation (1 000 
r/min for 5 min), resuspended with precooled 70% ethanol 
and 4 曟 immobilized overnight. The next day, immobilized 
cells were centrifuged at 800 r/min for 5 min, 500 毺L 
propidium iodide (PI) was added (0.05‰ PI, 0.02‰ Rnase) 
to resuspend. Resuspension solution stand was kept at 4 曟 
away from light for 30 min and cell cycle was detected.
2.3.5. CD133+ cells detection by FCM
  After about 48 h DAPT treated SHG-44 cells (the above 5 
groups) were collected, digested with 25% trypsin, counted 
and adjusted to 1伊106/mL. They were centrifuged at 
1 000 r/minfor 5 min, 4 曟. The cells were resuspended and 
transferred into EP tubes (100 毺L/tube). 10 毺L FITC labeled 
CD133 antibody was added and no antibody was added 
in the control group. Them were kept away from light for
30 min, excess uncombined antibody was washed with PBS, 
centrifuged at 1 000 r/min 4 曟 for 5 min. Then 500 毺L PBS 
was added and percentage of CD133+ cells were detected. 
2.3.6. Notch-1,Delta-l and Hes-1 mRNA expression 
detection by RT-PCR
  48 hs later DAPT treated SHG-44 cells were collected 
and 1 mL Trizol was added into 2伊106 cells. Cells were 
digested to extract total RNA. RNA concenrations and purity 
were detected by nucleic acid and protein quantitation 
instrument. Takara RT-PCR kit was used to conduct reverse 
transcription in accordance with the instructions: 52 曟,
30 min; 99 曟, 5min; 5 曟, 5min, save, cDNA synthesized and 
PCR amplification. After PCR amplification, 1% agarose gel 
electrophoresis was undertaken to analyze the PCR products. 
Then electrophoresis pictures were obtained using gel 
image analysis system. Image analysis software Gene Tools 
were used to analyze results. PCR amplification primer and 
annealing temperature details were as follows (Table 1).
2.3.7. Notch-1, Delta-1, Hes-1 protein expression detection 
by western blotting
  48 h later, DAPT treated SHG-44 cells were collected. 
RIPA lysis buffer was used to extract total proteins and 
BCA method to determine protein concentrations. They 
were mixed well, and added with loading buffer to the 
Table 1
Primer sequences.
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precipitations and loaded to the gel. Then proteins were 
transferred from gel to the membrane, the blot was removed 
from the transfer apparatus and immediately placed into 
blocking buffer. They were probed with primary antibody 
rabbit anti-human Notch-1 (1:1 000), Delta-1 (1:800), Hes-1 
(1:1 000) in TTBS/1% NFDM at 4 曟 overnight and was rinsed. 
Them were combined with HRP labeled second antibody and 
rinsed again. Finally, color development with HRP-ECL was 
detected.
3. Results
3.1. Cell morphology 
  Significant morphology and quantity changes occurred 
to DAPT treated SHG-44 cells 48 h later. Group A (control 
group) had the largest quantities of cells, a large part of 
which was spindle cells, while abnormal cells accounted 
for a relatively lower proportion. Cells adhension was not 
decreased and cells arranged intensively in order on the 
bottom of plates. The number of cells in group B was slightly 
decreased and exhibited no change in morphology. The 
number of DAPT (1.0 毺mol/L) treated SHG-44 cells in group 
C was significantly decreased, in which the percentage 
of abnormal and large-volume cells increased. Cells 
distributed onto the bottom of plates sparsely. The numbers 
of cells in group D and E were significantly decreased, 
wherein necrotic dead cells were observed. The remaining 
viable cells were abnormal in morphology, irregular border 
and suspended in culture medium because they could not 
adhere to the bottom easily (Figure 1A-E). 
 
Figure 1. SHG-44 cells treated by DAPT at different concentration. 
phase contrast microscope, 100伊. A: 0 毺mol/L; B: 0.5毺mol/L; C: 1.0
毺mol/L; D: 5.0毺mol/L; E: 10.0 毺mol/L.
3.2. MTT results
  Cell viability in each group was detected by MTT. 
Compared with those in group A, proliferation of SHG-
44 cells in group B, C, D and E were inhibited by DAPT. 
For group B and A, the results were significantly different 
(P<0.05). However, cell viability of group B was significantly 
higher than those in group C, D and E (P<0.05). The results 
showed that increased inhibition effect was related to 
increased DAPT concentrations. However there was no 
difference among group C, D and E (P>0.05). It indicated 
that DAPT is a concentration-dependent inhibitor that 
may obviously inhibit SHG-44 cells proliferation. As 
concentration of DAPT higher than 1.0 毺mol/L showed no 
more obvious disparities in cell inhibition, concentration of 
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Figure 2. Growth curve of SHG-44 cells treated by DAPT at different 
concentration.
3.2. DAPT on SHG-44 cell cycle
  Compared with group A, DAPT treated SHG-44 cells 
in group B, C, D and E were increased in quantities at 
stage G0/G1, while decreased at stage S (P<0.05). Change 
of the percentages of cells at each stage in group B was 
significantly less than those in group C, D and E (P<0.05), 
while there were no differences among group C, D and E 
(P>0.05). It indicated that SHG-44 cells may be stopped 
at stage G1/G0 and percentages of cells at stage S were 
decreased, especially at the concentration of 1.0 毺mol/L 
group (Table 2).
3.3. CD133+ TSC percentages
  48 h after SHG-44 cells in group B, C, D and E were 
Table 2
Percent in cell cycle of SHG-44 cells treated by DAPT at different concentration(mean依sd, n=20, %).
Group G0/G1 S G2/M
A (0 毺mol/L) 56.25依1.31 28.47依1.24 15.38依0.87
B (0.5 毺mol/L) 61.97依5.80
*  23.89依4.42*    15.25依3.61☆
C (1.0 毺mol/L) 67.19依4.72
*#   18.57依2.30*#       14.05依1.53☆△
D (5.0 毺mol/L)  68.73依7.68
*△     18.45依2.20*△       13.82依1.36☆△
E (10.0 毺mol/L) 70.58依9.44
*△     16.39依3.35*△       13.03依3.41☆△
*P<0.05 compared with A group; ☆P>0.05 vs. A group; #P<0.05 post-group vs. pro-group; △P>0.05 post-group vs. pro-group.
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treated by DAPT, CD133+ cell percentages were decrease, 
with expression level of (25.75依2.13)%, (19.57依3.04)%, (15.91
依2.98)%, (10.15依2.33)% and (7.02依3.17)%, respectively. 
Compared with group A, CD133+ cell percentages in group B, 
C, D and E were decreased significantly (P<0.05), which was 
inversely proportion to drug concentrations (P<0.05). It is 
demonstrated that DAPT significantly decreased CD133+ TSC 
percentages in a dose-dependent manner.
3.5. RT-PCR results
  RT-PCR assay was used to detect changes of expression 
levels of Notch-1, Delta-1 and Hes-1 mRNA of DAPT treated 
SHG-44 cells in each group 48 h later. The results showed 
that similar tendency of different expressions of genes like 
Notch-1, Delta-1 and target gene Hes-1 acting upstream 
of the Notch signaling pathway was observed. Compared 
with those in group A, the expression levels of the three 
genes in cells of DAPT treated four groups were significantly 
decreased (P<0.05). The expression level in group B was 
significantly higher than group C, D and E (P<0.05), while 
no statistical differences were observed in among group C, 
D and E (P>0.05). It is demonstrated that, DAPT could down 
regulate expression levels of Notch-1, Delta-1 and Hes-1 
in SHG-44 cells, wherein group C (1.0 毺mol/L DAPT) had 
the similar gene expression level with group C and D (higher 
than 1.0 毺mol/L DAPT). Therefore, it was highly suggested 
to take 1.0 毺mol/L DAPT as the best choice (Figure 3). 






Figure 3. SHG-44 gene expression treated by DAPT at different 
concentration.
A: 0 毺mol/L; B: 0.5 毺mol/L; C: 1.0 毺mol/L; D: 5.0 毺mol/L; E: 
10.0 毺mol/L.
3.6.  Western  blotting  results
  48 h later, protein levels of Notch-1, Delta-1 and Hes-1 
gene expression of DAPT treated SHG-44 cells in each group 
were measured by Western blotting. The results showed that 
similar tendency of the three critical protein expression was 
observed. Compared with those of group A, protein levels 
of group B, C, D and E significantly decreased (P<0.05), 
wherein those in group B were higher than group C, D and 
E (P<0.05). However, there was no statistical differences 
among group C, D and E (P>0.05). It is suggested that DAPT 
could down regulate protein level of upstream gene Notch-1, 
Delta-l and target gene Hes-1 in Notch signaling pathway 
of SHG-44 cells and DAPT concentrations higher than
1.0 毺mol/L (group C) had the similar down-regulation effect 
in group D and E (Figure 4).










Figure 4. SHG-44 protein expression treated by DAPT with different 
concentration.
A: 0 毺mol/L; B: 0.5 毺mol/L; C: 1.0 毺mol/L; D: 5.0 毺mol/L; E: 
10.0 毺mol/L.
4. Discussion
  Glioma is the most common intracranial malignant tumor 
with a relatively high morbidity and mortality, which is often 
hard to control. The traditional chemotherapy regimens 
targeting tumor cells with highly proliferative ability could 
removal or kill tumor tissues and cells to the largest extent. 
The latest research shows that the presence of TSC is 
the source of tumor relapse, metastasis and resistance to 
chemotherapy. Notch signaling pathway plays a vital role in 
the proliferation and differentiation of stem cells and tumor 
stem cells. In addition, there are abnormal activations of 
Notch signaling pathway in several neoplasms[3-5]. 
  Notch signaling pathway comprises Notch receptor, Notch 
ligand and SCL (a DNA binding protein). The Notch receptor 
has undergone two proteolysises successively after the 
combination of ligand and receptor. The second proteolysis 
is 毭-secretase (presenilin, PS), which is the critical enzyme 
during Notch signal activation[6,7] resulting in protein 
incision at the intramembrane locus near the transmembrane 
domain. NICD with nuclear localization signal is then 
released, translocated into the nucleus and interacts with 
DNA binding protein CSL to activate transcription, resulting 
in activation of downstream Hes, Hey, HERP and bHLH 
genes and influencing cell proliferation, differentiation and 
apoptosis[8,9]. A 毭-secretase inhibitor could block NICD 
generation in Notch signaling pathway, thus inhibiting 
abnormal cell differentiation, proliferation and apoptasis 
originating from NICD. Furthermore, a 毭-secretase inhibitor 
interferes with Notch signal transduction between tumor 
cells and vascular endothelial cells to block angiogenesis. 
DAPT is a well-known, artificially synthesized 毭-secretase 
inhibitor that effectively blocks Notch signaling pathway and 
has proven to have great potential in anti-tumor effect[10-13].
  In our study, SHG-44 cell line was treated by different 
concentrations of DAPT to observe cell proliferations and 
explore its possible mechanisms. MTT method was used to 
detect DAPT treated SHG-44 cells and results show DAPT 
significantly inhibit cells growth in a dose-dependent 
manner. When DAPT concentrations increased to 1.0 毺mol/L,
the inhibition effect was most obvious and showed no 
differences with higher concentration groups, indicating
1.0 毺mol/L is the maximal effective concentration in 
clinical application. Cell cycle detection by flow cytometry 
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showed a large percentage of SHG-44 cells stoped at stage 
G0/G1 and the percentages of cells at stage S decreased. 
The inhibition effect enhanced with DAPT concentrations 
increased. Western blotting and RT-PCR assay shows 
different concentrations of DAPT (1.0, 5.0, 10.0 毺mol/L) may 
down regulate mRNA and protein expression levels of critical 
factors (Notch-1, Delta-1, Hes-1)in Notch signaling pathway 
of SHG-44 cells in a dose-dependent manner. Prior study[14] 
detected mRNA and protein expression levels of Notch-1 
and ligands Delta-1,Jagged-1 in 6 human brain glioma 
cell lines and primary human brain glioma, indicating their 
over expression. In addition, immumohistochemical staining 
results shows moderate and high level of Notch-1 protein 
expressions in the majority of grade 栻 and 栿 glioma. The 
results proved the prior study results, showing the severity 
of tumors is in correlation with Notch signaling activation. 
Based on MTT and results from cell cycle detection, 
inhibition of DAPT on glioma cell line SHG-44 proliferation 
may be related to the down regulation of Notch-1, Delta-1 
and Hes-1mRNA. Furthermore, Hes-1 protein could promote 
cell proliferation by inhibition on Cyclin-dependent kinase 
inhibitor p27 trancription[15-18] and down regulate Hes-1 
expression to inhibit cell proliferation. Besides, our study 
shows that CD133+ decrease to approximate one fourth in 
SHG-44 cell line by DAPT. Fan et al[19] discovered CDD133+ 
in SHG-44 cells decreased to one fifth the original quantities 
by blocking Notch signaling in BTSC cultures in vitro. Our 
experimental results are similar with these findings. CD133+ 
is considered as the characteristic indicator of glioma stem 
cells where the CD133+ cell expression decrease indicating 
significantly decrease of SHG-44 cell line in TSCs. Inhibiting 
Notch signaling pathway could obviously suppress TSCs 
proliferation, the mechanism of which may be related with 
down-regulation of Notch-1, Delta-1 and Hes-1 mRNA.
It is a critical mean to inhibit tumor cell proliferation by 
decreasing the number of TSCs, thus providing an effective 
regimen to cure malignant tumor.
  We can conclude that DAPT may suppress SHG-44 cell 
proliferation by blocking Notch signaling pathway wherein 
the concentration of 1.0 毺mol/L achieved the most 
significant effect due to low cytotoxicity and less adverse 
drug reactions. In addition, the study has proven DAPT may 
obviously inhibit TSCs proliferation and expected to be the 
effective drug for glioma treatment or serve as an adjuvant 
drug to improve radiotherapy and chemotherapy sensitivity. 
Further studies are still needed to explore the specific 
mechanism of DAPT anti-tumor effect, especially on TSCs, 
and may provide guideline to cure glioma. 
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